
Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
Recovery from depression is a process, and patients need steady, realistic guidance to move through each stage. Insights here.